Evidence map›Paper›PMID 38540341›Full record

ArticleGenes2024

Effects of Paraquat, Dextran Sulfate Sodium, and Irradiation on Behavioral and Cognitive Performance and the Gut Microbiome in A53T and A53T-L444P Mice.

Ariel Chaklai, Abigail O'Neil, Shrey Goel, Nick Margolies, Destine Krenik, Ruby Perez, Kat Kessler, Elizabeth Staltontall, Hong Ki Eric Yoon, Montzerrat Pantoja and 6 more

Open access · goldAbstract read
In one paragraph

Article in Genes, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Exploring the relationship betweenFrontiers in neuroscience · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 1 country.

Ariel ChaklaiDepartment of Behavioral Neuroscience, Oregon Health & Science University, Portland, OR 97239, USA.
Abigail O'NeilDepartment of Behavioral Neuroscience, Oregon Health & Science University, Portland, OR 97239, USA.
Shrey GoelDepartment of Behavioral Neuroscience, Oregon Health & Science University, Portland, OR 97239, USA.
Nick MargoliesDepartment of Behavioral Neuroscience, Oregon Health & Science University, Portland, OR 97239, USA.
Destine KrenikDepartment of Behavioral Neuroscience, Oregon Health & Science University, Portland, OR 97239, USA.
Ruby PerezDepartment of Behavioral Neuroscience, Oregon Health & Science University, Portland, OR 97239, USA.
Kat KesslerDepartment of Behavioral Neuroscience, Oregon Health & Science University, Portland, OR 97239, USA.
Elizabeth StaltontallDepartment of Behavioral Neuroscience, Oregon Health & Science University, Portland, OR 97239, USA.
Hong Ki Eric YoonDepartment of Behavioral Neuroscience, Oregon Health & Science University, Portland, OR 97239, USA.
Montzerrat PantojaDepartment of Behavioral Neuroscience, Oregon Health & Science University, Portland, OR 97239, USA.
Keaton StagamanDepartment of Microbiology, Oregon State University, Corvallis, OR 97331, USA.
Kristin KasschauDepartment of Microbiology, Oregon State University, Corvallis, OR 97331, USA.
Vivek UnniDepartment of Neurology, Oregon Health & Science University, Portland, OR 97239, USA.
Robert DuvoisinDepartment of Chemical Physiology and Biochemistry, Oregon Health & Science University, Portland, OR 97239, USA.
Thomas SharptonDepartment of Microbiology, Oregon State University, Corvallis, OR 97331, USA.
Jacob RaberDepartment of Behavioral Neuroscience, Oregon Health & Science University, Portland, OR 97239, USA.ORCID 0000-0002-9861-9893
Oregon Health & Science University · USOregon State University · USOregon National Primate Research Center · US

Funding

Research Education ComponentP30AG066518 · NIA · OREGON HEALTH & SCIENCE UNIVERSITY · PI KEVIN M DUFF, Lisa C Silbert · 2020 to 2026
$28.6M
Impacts of Benzo[a]pyrene on Microbiome Development across Lifespan and Generations and the Behavioral ConsequencesR01ES030226 · NIEHS · OREGON STATE UNIVERSITY · PI SHARPTON, THOMAS JEFFERSON · 2019 to 2023
$2.1M
Role of human apolipoprotein E isoforms in long-term effects of West Nile Virus exposure on Alzheimer's disease-related behavioral alteration, cognitive injury, neuroinflammation, and neuropathologyR21AG079158 · NIA · OREGON HEALTH & SCIENCE UNIVERSITY · PI HIRSCH, ALEC J, RABER, JACOB · 2023 to 2024
$424k
Department of Defence W81XWH2110703National Institute of Health AG079158NIA NIH HHS P30 AG066518NIA NIH HHS R21 AG079158NIEHS NIH HHS R01 ES030226
6 · The paper itself

Abstract

Heterozygous carriers of the glucocerebrosidase 1 (GBA) L444P Gaucher mutation have an increased risk of developing Parkinson's disease (PD). The GBA mutations result in elevated alpha synuclein (aSyn) levels. Heterozygous mice carrying one allele with the L444P mutation knocked-into the mouse gene show increased aSyn levels and are more sensitive to motor deficits following exposure to the neurotoxin (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) MPTP than wild-type mice. Paraquat (PQ), a herbicide, increases PD risk in most studies. Its effects on the brain involve alterations in the gut microbiome. Exposure to dextran sulfate sodium (DSS), a mouse model of colitis, can be used to determine whether gut microbiome alterations are sufficient to induce PD-relevant phenotypes. We rederived the A53T-L444P and A53T mouse lines to assess whether PQ, PQ in combination with radiation exposure (IR), and DSS have differential effects in A53T and A53T-L444P mice and whether these effects are associated with alterations in the gut microbiome. PQ and PQ + IR have differential effects in A53T and A53T-L444P mice. In contrast, effects of DSS are only seen in A53T-L444P mice. Exposure and genotype modulate the relationship between the gut microbiome and behavioral performance. The gut microbiome may be an important mediator of how environmental exposures or genetic mutations yield behavioral and cognitive impacts.

Indexed as

Gastrointestinal MicrobiomeParkinson DiseaseAnimalsCognitionDextran SulfateGlucosylceramidaseMiceParaquatDextran SulfateGlucosylceramidaseParaquatalpha synuclein mutationbehavioral testingcognitive testingdextran sulfate sodiumGaucher mutationgut microbiomeirradiationparaquat

Identifiers

PMID38540341
PMCPMC11154584
OpenAlexW4392156555

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.